Prevention of HBV-related HCC

被引：0
|
作者：
Liaw, Yun-Fan [1 ,2 ]
机构：
[1] Chang Gung Mem Hosp, Liver Res Unit, Taipei, Taiwan
[2] Chang Gung Univ, Taipei, Taiwan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [41] Mechanisms of HBV-related hepatocarcinogenesis
    Neuveut, Christine
    Wei, Yu
    Buendia, Marie Annick
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 594 - 604
  • [42] Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC
    Nagamatsu, H
    Kumashiro, R
    Itano, S
    Matsugaki, S
    Sata, M
    [J]. HEPATOLOGY RESEARCH, 2003, 26 (04) : 293 - 301
  • [43] A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
    Yang, Yu
    Wen, Feng
    Li, Jianliang
    Zhang, Pengfei
    Yan, Wenhui
    Hao, Ping
    Xia, Feng
    Bi, Feng
    Li, Qiu
    [J]. LIVER INTERNATIONAL, 2015, 35 (09) : 2147 - 2154
  • [44] HBsAg seroclearance and reduction in late recurrence of HBV-related HCC: Causality or co-existence?
    Diao, Yong-Kang
    Kong, Qing-Yu
    Yang, Tian
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1468 - 1469
  • [45] Identification of Key Genes in the HBV-Related HCC Immune Microenvironment Using Integrated Bioinformatics Analysis
    Ding, Wei
    Zhang, Zheng
    Ye, Nianyuan
    Zhuang, Ling
    Yuan, Zhiping
    Xue, Wenbo
    Tan, Yulin
    Xu, Xuezhong
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [46] Serum levels of trypsin inhibitor Kazal1 (SPINK1) increased in patients with HBV-related hepatocellular carcinoma, predicts poor prognosis of HBV-related HCC
    Yan, R.
    Wang, Q.
    Yang, K.
    Zhang, H.
    Guan, S.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1049 - 1049
  • [47] Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis
    Mao, Xianhua
    Cheung, Ka Shing
    Peng, Chengzhi
    Mak, Lung-Yi
    Cheng, Ho Ming
    Fung, James
    Peleg, Noam
    Leung, Howard H-W
    Kumar, Rajneesh
    Lee, Jeong-Hoon
    Shlomai, Amir
    Yuen, Man-Fung
    Seto, Wai-Kay
    [J]. HEPATOLOGY, 2023, 77 (05) : 1735 - 1745
  • [48] Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC
    Lou, Weiyang
    Liu, Jingxing
    Ding, Bisha
    Chen, Danni
    Xu, Liang
    Ding, Jun
    Jiang, Donghai
    Zhou, Lin
    Zheng, Shusen
    Fan, Weimin
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [49] The Different Effects of Nucleotide and Nucleoside Analogues on the Prognosis of HBV-Related HCC After Curative Resection
    Zhang, Xiaoyun
    Li, Chuan
    Wen, Tianfu
    Yan, Lunan
    Yang, Jiayin
    Tang, Hong
    Lu, Changli
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (06) : 1419 - 1429
  • [50] Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC
    Huang, Kang
    Lu, Zhongshan
    Li, Ling
    Peng, Guizhu
    Zhou, Wei
    Ye, Qifa
    [J]. HUMAN CELL, 2021, 34 (06) : 1830 - 1842
12345